Wu JY, Zhang W, Pu J, Liu Y, et al. A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicity. Vaccine 2024 May 24:S0264-410X(24)00559-0. doi: 10.1016/j.vaccine.2024.
PMID: 38796326